These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15739622)

  • 1. Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003.
    Bonnet F; Balestre E; Bernardin E; Pellegrin JL; Neau D; Dabis F;
    Antivir Chem Chemother; 2005; 16(1):63-7. PubMed ID: 15739622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic hyperlactataemia: predictive value, natural history and correlates.
    McComsey GA; Yau L
    Antivir Ther; 2004 Apr; 9(2):205-12. PubMed ID: 15134182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients.
    Hocqueloux L; Alberti C; Feugeas JP; Lafaurie M; Lukasiewicz E; Bagnard G; Carel O; Erlich D; Molina JM
    HIV Med; 2003 Jan; 4(1):18-23. PubMed ID: 12534955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.
    Lactic Acidosis International Study Group
    AIDS; 2007 Nov; 21(18):2455-64. PubMed ID: 18025882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matched case-control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy.
    Datta D; Moyle G; Mandalia S; Gazzard B
    HIV Med; 2003 Oct; 4(4):311-4. PubMed ID: 14525541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.
    Moyle GJ; Datta D; Mandalia S; Morlese J; Asboe D; Gazzard BG
    AIDS; 2002 Jul; 16(10):1341-9. PubMed ID: 12131210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
    Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
    Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South Africa.
    Dlamini J; Ledwaba L; Mokwena N; Mokhathi T; Orsega S; Tsoku M; Kowo H; Proschan M; Khabo P; Maja P; Hadigan C
    Antivir Ther; 2011; 16(4):605-9. PubMed ID: 21685549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
    Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
    Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
    Osler M; Stead D; Rebe K; Meintjes G; Boulle A
    HIV Med; 2010 Feb; 11(2):121-9. PubMed ID: 19702629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
    Hwang SW; Leo YS
    Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line therapy and mitochondrial damage: different nucleosides, different findings.
    Blanco F; García-Benayas T; José de la Cruz J; González-Lahoz J; Soriano V
    HIV Clin Trials; 2003; 4(1):11-9. PubMed ID: 12577192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir].
    Tanaka K; Fukahori S; Jojima H; Fujimatsu Y; Shiraishi K; Tanaka M; Okubo Y; Honda J; Oizumi K
    Kansenshogaku Zasshi; 1999 Dec; 73(12):1232-5. PubMed ID: 10655686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.